Surgical Treatment of a 4-Year-Old Child with Hypertrophic Obstructive Cardiomyopathy: Case Report
DOI:
https://doi.org/10.1532/hsf.1383Abstract
The incidence of pediatric hypertrophic obstructive cardiomyopathy is low. The lesions usually involve the left ventricle or ventricular septum, leading to either left or right ventricular outflow tract stenosis. However, combined left and right ventricular outflow tract stenosis is rare, and the surgical treatment is limited, especially in children. Surgery to release the obstruction was performed successfully in a 4-year-old child with right and left ventricular outflow tract obstruction together with a hypertrophic cardiomyopathy. The result was excellent.References
Kazui T, Niinuma H, Yamasaki M, Abe K, Watanabe S, Kawazoe K. 2012. Septal myectomy and myotomy attenuate left ventricular hyper-contractility in a child with hypertrophic obstructive cardiomyopathy. Ann Thorac Cardiovasc Surg 18:162-5.
Lipshultz SE, Sleeper LA, Towbin JA, et al. 2003. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647-55.
Maron BJ et al. 2003. American college of cardiology/European society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy-a report of the American college of cardiology task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelines committee to develop an expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 42:1687-1713.
Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK. 2004. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg 127:481-9.
Morimoto S, Sekiguchi M, Uemura A, et al. 2003. Cardiac Muscle cell disorganization in apical hypertrophic cardiomyopathy. Jpn Heart J 144:505-13.
Prinz C, Farr M, Hering D, Horstkotte D, Faber L. 2011. The diagnosis and cardiomyopathy. Deutsches Arzteblatt International. Dtsch Arztebl Int 108:209-15.
Tardiff JC, Factor SM, Tompkins BD, et al. 1998. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. The American Society for Clinical Investigation, Inc. 101:2800-11.
